So, if you want to eliminate poly wear, a one-piece implant will do that for you.
So, I would propose using modularity when you need it, but not always. And I’d say in two-thirds of our cases we can use a one-piece implant.
These are the 3 general conditions when I use modularity:
- The first is if you want to change the articular congruity with an anterior stabilized or “dished” or ultra-congruent implant. I think it’s an excellent option if your flexion laxity is a little bit greater than your extension, then you don’t want to mess with the bone cuts, you can add an ultra-congruent type device. If you want to get into 1mm increments for balancing the gaps, I think we use modularity in those cases with the 11 or 13 implants. If you want to use a PS or perhaps you have iatrogenic imperfecta and you might need the little bit more stabilization of a PS+ type implant, we’ll use modularity.
- And then as Aaron pointed out, stems, augments are sort of the rare primary case where you need something else.
- Or perhaps in the very young, we still use one-piece implants, but if you want some other type of polyethylene option, modularity works.
Our premise is: we use one-piece implants with modular capabilities. And I would say, “What are the results of this workflow?” So, we’ve done this for a number of years.
We looked at a 10-year period. We’d done roughly 10,000 knee arthroplasties of all flavors. The indications for selecting one-piece versus modular implants were based on the surgeon’s selection. We found a sub-cohort of 2,000 knees with the same articulation, with two different designs. One was modular and one was a one-piece that had the ability to remove the polyethylene later if need be. Roughly half of them were the one-piece implant. It’s a cemented cobalt-chromium tray, standard demographics for almost all series.
If you look at reoperation for the modular prosthesis, 0.6% required a reoperation at mid-term follow-up. Two of these were for infection; 4 were aseptic (Kaplan Meier Survivorship; p=0.76. Wilcoxon test). There was no difference in survivorship between the one-piece implants at early follow-up compared to the non-modular implants.

